bromodeoxyuridine has been researched along with fluoxetine in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 26 (55.32) | 29.6817 |
| 2010's | 21 (44.68) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duman, RS; Eisch, AJ; Malberg, JE; Nestler, EJ | 1 |
| Chen, J; Duman, RS; Fujioka, T; Kim, JE; Lee, R; Malberg, J; Nakagawa, S; Tsuji, S | 1 |
| Duman, RS; Malberg, JE | 1 |
| Duman, RS; Fujioka, T; Kodama, M | 1 |
| Beauquis, J; De Nicola, A; Homo-Delarche, F; Roig, P; Saravia, F | 1 |
| Chen, H; Dwivedi, Y; Pandey, GN | 1 |
| Chang, YC; Ho, CJ; Huang, AM; Huang, CC; Lee, HT; Tzeng, SF; Yu, L | 1 |
| Abumaria, N; Czéh, B; Domenici, E; Fuchs, E; Hiemke, C; Müller-Keuker, JI; Rygula, R | 1 |
| Eisch, AJ; Fischer, SJ; Lagace, DC | 1 |
| Banasr, M; Duman, RS; Gourley, SL; Li, XY; Taylor, JR; Valentine, GW | 1 |
| Cameron, MD; Gulati, A; Miller, BH; Pletcher, MT; Schultz, LE | 1 |
| Cho, KO; Choi, YS; Kim, SY | 1 |
| Ibi, D; Kamei, H; Koike, H; Kuwahara, Y; Mizoguchi, H; Nabeshima, T; Nagai, T; Takuma, K; Tsuritani, K; Yamada, K; Yoneda, Y | 1 |
| Englund, U; Flagstad, P; Johansen, FF; Kristjansen, PE; Marcussen, AB | 1 |
| Bannerman, D; Flint, J; Huang, GJ | 1 |
| Hutson, PH; Murray, F; Smith, DW | 1 |
| Hof, PR; Navailles, S; Schmauss, C | 1 |
| Cowen, DS; Fornal, CA; Jacobs, BL; Takase, LF | 1 |
| Cai, HH; Chen, L; Ding, XS; Li, WL; Liu, N; Luo, CX; Wang, B; Zhou, QG; Zhu, DY | 1 |
| Aigner, L; Aigner, R; Bogdahn, U; Caioni, M; Couillard-Despres, S; Kandasamy, M; Stadler, K; Wuertinger, C | 1 |
| Anderson, BT; Balu, DT; Hodes, GE; Lucki, I | 1 |
| Castrén, E; Wu, X | 1 |
| Guo, YJ; Sui, YX; Sun, Y; Wang, SH; Zhang, ZJ | 1 |
| Antonijevic, IA; Artymyshyn, RP; Craig, DA; David, DJ; Drew, M; Gardier, AM; Gerald, C; Guiard, BP; Guilloux, JP; Hen, R; Leonardo, ED; Marsteller, D; Mendez, I; Rainer, Q; Samuels, BA; Wang, JW | 1 |
| Abel, T; Chung, H; Jang, DJ; Kaang, BK; Kim, B; Kim, H; Kim, SH; Kim, WR; Kim, YS; Ko, HG; Lee, JS; Lee, MY; Lee, N; Son, H; Son, J; Sun, W; Zhuo, M | 1 |
| Hodes, GE; Santollo, J; Shors, TJ; Van Kooy, J; Yang, L | 1 |
| Beyhan, Z; Chang, EA; Cibelli, JB; Ko, T; Lookingland, KJ; Madhukar, BV; Siripattarapravat, K; Yoo, MS | 1 |
| Al-menhali, N; Bartlett, PF; Catts, VS; Colditz, MJ; Coulson, EJ; Osborne, GW | 1 |
| Barden, N; Gabriel, C; Hamon, M; Lanfumey, L; Lelievre, V; Melfort, M; Mocaër, E; Païzanis, E; Renoir, T; Saurini, F | 1 |
| Calandra, T; Castro, JE; Conboy, L; Lashuel, HA; Sakouhi-Ouertatani, H; Sandi, C; Varea, E | 1 |
| Hui, J; Li, L; Liu, S; Sui, Y; Wang, Y; Xi, G; Zhang, L; Zhang, X; Zhang, Z | 1 |
| Miyakawa, T; Ohira, K | 1 |
| Herbert, J; Liu, JX; Pinnock, SB | 1 |
| Kirsch, F; Meyer, A; Moraru, A; Pitzer, C; Plaas, C; Schneider, A; Spoelgen, R; Vogt-Eisele, A | 1 |
| Banas, SM; Belmer, A; Boutourlinsky, K; Diaz, SL; Doly, S; Fernández, S; Maroteaux, L; Mazot, P; Moutkine, I; Narboux-Nême, N; Roumier, A | 1 |
| Bath, KG; Chao, MV; Dincheva, I; Jing, DQ; Lee, FS; Neeb, CC; Ninan, I; Pattwell, SS | 1 |
| Bennett, G; ElBeltagy, M; Lyons, L; Wigmore, P | 1 |
| Banasr, M; Duman, RS; Duric, V; Elsayed, M; Fournier, NM; Licznerski, P | 1 |
| Hellweg, R; Hühnchen, P; Klaissle, P; Lesemann, A; Pilhatsch, M; Reinel, C; Steiner, B; Winter, C | 1 |
| Belzung, C; Minier, F; Rainer, Q; Surget, A; Tanti, A | 1 |
| Belzung, C; Gaillard, P; Girault, V; Leman, S; Nollet, M; Tanti, A | 1 |
| Belzung, C; Brizard, B; Devers, S; Girault, V; Leguisquet, AM; Surget, A; Tanti, A; Westphal, WP | 1 |
| Chang, T; Chen, YC; Peng, ZW; Tan, QR; Wang, HN; Wang, Y; Wu, WJ; Zhang, RG | 1 |
| Chen, D; Huang, J; Jiang, L; Li, L; Liu, C; Mao, R; Tong, J; Wang, H | 1 |
| Filipkowski, RK; Jedynak, P; Kaczmarek, L; Kos, T; Sandi, C | 1 |
| Caron, MG; Sachs, BD | 1 |
| Barker, RA; Begeti, F; Choi, ML; Kim, N | 1 |
47 other study(ies) available for bromodeoxyuridine and fluoxetine
| Article | Year |
|---|---|
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus.
Topics: Animals; Antidepressive Agents; Antigens, Differentiation; Bromodeoxyuridine; Cell Count; Cell Division; Cell Survival; Fluorescent Antibody Technique; Fluoxetine; Hippocampus; Male; Morpholines; Neurons; Rats; Rats, Sprague-Dawley; Reboxetine; Tranylcypromine | 2000 |
Localization of phosphorylated cAMP response element-binding protein in immature neurons of adult hippocampus.
Topics: Animals; Antidepressive Agents; Antigens, Differentiation; Bromodeoxyuridine; Cell Division; Cell Survival; Colforsin; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Fluoxetine; Hippocampus; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Neural Cell Adhesion Molecule L1; Neurons; PC12 Cells; Phosphorylation; Rats; Rolipram; Selective Serotonin Reuptake Inhibitors; Sialic Acids; Sialyltransferases | 2002 |
Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Bromodeoxyuridine; Cell Count; Cell Division; Conditioning, Operant; Corticosterone; Depression; Disease Models, Animal; Electroshock; Escape Reaction; Fluoxetine; Helplessness, Learned; Hippocampus; Male; Nerve Growth Factors; Nuclear Proteins; Radiation-Sensitizing Agents; Rats; Rats, Sprague-Dawley; Reaction Time; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Stress, Psychological; Time Factors | 2003 |
Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Benzodiazepines; Bromodeoxyuridine; Cell Count; Cell Proliferation; Drug Administration Schedule; Drug Interactions; Endothelial Growth Factors; Fluoxetine; Hippocampus; Immunohistochemistry; Male; Nerve Growth Factors; Nuclear Proteins; O Antigens; Olanzapine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; S100 Calcium Binding Protein beta Subunit; S100 Proteins | 2004 |
Reduced hippocampal neurogenesis and number of hilar neurones in streptozotocin-induced diabetic mice: reversion by antidepressant treatment.
Topics: Animals; Antidepressive Agents, Second-Generation; Bromodeoxyuridine; Cell Count; Cell Proliferation; Cytoplasmic Granules; Diabetes Mellitus, Experimental; Fluorescent Antibody Technique; Fluoxetine; Hippocampus; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Neuroglia; Neuronal Plasticity; Neurons | 2006 |
Hippocampal cell proliferation regulation by repeated stress and antidepressants.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Bromodeoxyuridine; Cell Count; Cell Proliferation; Corticosterone; Desipramine; Electroshock; Fluoxetine; Helplessness, Learned; Hippocampus; Immunohistochemistry; Male; Neurons; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Stress, Psychological | 2006 |
Early-life fluoxetine exposure reduced functional deficits after hypoxic-ischemia brain injury in rat pups.
Topics: Aging; Animals; Animals, Newborn; Antimetabolites; Blotting, Western; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cerebral Cortex; Cyclic AMP Response Element-Binding Protein; Dentate Gyrus; Female; Fluoxetine; Hippocampus; Hypoxia-Ischemia, Brain; Locomotion; Male; Maze Learning; Microscopy, Confocal; Neurons; Neuroprotective Agents; Organ Size; Phosphorylation; Psychomotor Performance; Rats; Reverse Transcriptase Polymerase Chain Reaction; Selective Serotonin Reuptake Inhibitors; Synapsins | 2006 |
Chronic social stress inhibits cell proliferation in the adult medial prefrontal cortex: hemispheric asymmetry and reversal by fluoxetine treatment.
Topics: Animals; Body Weight; Bromodeoxyuridine; Cell Count; Cell Differentiation; Cell Proliferation; Cell Survival; Chronic Disease; Dentate Gyrus; Depressive Disorder; Fluoxetine; Functional Laterality; Male; Neuroglia; Neurons; Organ Size; Prefrontal Cortex; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Social Behavior; Stem Cells; Stress, Psychological | 2007 |
Gender and endogenous levels of estradiol do not influence adult hippocampal neurogenesis in mice.
Topics: Aging; Animals; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Estradiol; Estrous Cycle; Female; Fluoxetine; Hippocampus; Male; Mice; Mice, Inbred C57BL; Neurons; Ovariectomy; Selective Serotonin Reuptake Inhibitors; Sex Characteristics; Sex Factors; Species Specificity; Stem Cells | 2007 |
Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Bromodeoxyuridine; Cell Proliferation; Cerebral Cortex; Conditioning, Operant; Corticosterone; Disease Models, Animal; Fluoxetine; Ki-67 Antigen; Male; Neuroglia; Neurons; Rats; Rats, Sprague-Dawley; Stress, Psychological | 2007 |
Genetic regulation of behavioral and neuronal responses to fluoxetine.
Topics: Analysis of Variance; Animals; Behavior, Animal; Bromodeoxyuridine; Cell Differentiation; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluoxetine; Gene Expression Regulation; Hippocampus; Immobility Response, Tonic; Male; Mice; Mice, Inbred Strains; Nerve Tissue Proteins; Oligonucleotide Array Sequence Analysis; Selective Serotonin Reuptake Inhibitors; Time Factors | 2008 |
Fluoxetine does not affect the ischemia-induced increase of neurogenesis in the adult rat dentate gyrus.
Topics: Animals; Bromodeoxyuridine; Dentate Gyrus; Fluoxetine; Ischemic Attack, Transient; Male; Nerve Regeneration; Prosencephalon; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2007 |
Social isolation rearing-induced impairment of the hippocampal neurogenesis is associated with deficits in spatial memory and emotion-related behaviors in juvenile mice.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Behavior, Animal; Bromodeoxyuridine; Cell Proliferation; Dentate Gyrus; DNA-Binding Proteins; Emotions; Fluoxetine; Gene Expression Profiling; Gene Expression Regulation, Developmental; Hippocampus; Male; Memory Disorders; Mental Disorders; Mice; Mice, Inbred ICR; Neuronal Plasticity; Neurons; Nuclear Receptor Subfamily 4, Group A, Member 2; Selective Serotonin Reuptake Inhibitors; Social Behavior; Social Isolation; Stem Cells; Transcription Factors | 2008 |
Increase in neurogenesis and behavioural benefit after chronic fluoxetine treatment in Wistar rats.
Topics: Animals; Behavior, Animal; Bromodeoxyuridine; Cell Count; Cell Proliferation; Dentate Gyrus; Doublecortin Domain Proteins; Doublecortin Protein; Drug Administration Schedule; Feeding Behavior; Fluoxetine; Ki-67 Antigen; Male; Microtubule-Associated Proteins; Neurons; Neuropeptides; Rats; Rats, Wistar; Reaction Time; Selective Serotonin Reuptake Inhibitors | 2008 |
Chronic fluoxetine treatment alters behavior, but not adult hippocampal neurogenesis, in BALB/cJ mice.
Topics: Animals; Behavior, Animal; Bromodeoxyuridine; Cell Proliferation; Doublecortin Domain Proteins; Drug Administration Schedule; Exploratory Behavior; Fluoxetine; Hippocampus; Ki-67 Antigen; Mice; Mice, Inbred BALB C; Microtubule-Associated Proteins; Neurons; Neuropeptides; Selective Serotonin Reuptake Inhibitors | 2008 |
Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice.
Topics: Adrenal Glands; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antimetabolites; Anxiety; Behavior, Animal; Bromodeoxyuridine; Cell Proliferation; Chemistry, Pharmaceutical; Corticosterone; Depression; Fluoxetine; Hippocampus; Imipramine; Immunohistochemistry; Lighting; Male; Mice; Organ Size; Swimming | 2008 |
Antidepressant drug-induced stimulation of mouse hippocampal neurogenesis is age-dependent and altered by early life stress.
Topics: Animals; Antidepressive Agents; Bromodeoxyuridine; Doublecortin Domain Proteins; Female; Fluoxetine; Hippocampus; Humans; Immunohistochemistry; Male; Maternal Behavior; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microtubule-Associated Proteins; Neurons; Neuropeptides; Species Specificity; Stress, Psychological; Weaning | 2008 |
Age-dependent decline in hippocampal neurogenesis is not altered by chronic treatment with fluoxetine.
Topics: Age Factors; Analysis of Variance; Animals; Biomarkers; Bromodeoxyuridine; Cell Count; Cell Differentiation; Cell Proliferation; Cell Survival; Dentate Gyrus; Fluoxetine; Hippocampus; Immunoenzyme Techniques; Injections, Intraperitoneal; Ki-67 Antigen; Male; Neurons; Random Allocation; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2008 |
Chronic fluoxetine treatment improves ischemia-induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke.
Topics: Analysis of Variance; Animals; Antimetabolites; Bromodeoxyuridine; Cell Count; Cognition Disorders; Disease Models, Animal; Fluoxetine; Infarction, Middle Cerebral Artery; Male; Maze Learning; Mice; Mice, Inbred C57BL; Neurogenesis; Neurons; Psychomotor Performance; Reaction Time; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Space Perception; Swimming; Time Factors; Zidovudine | 2009 |
Ageing abolishes the effects of fluoxetine on neurogenesis.
Topics: Age Factors; Aging; Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Brain; Bromodeoxyuridine; Cell Survival; Fluoxetine; Hippocampus; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neurogenesis; Neurons | 2009 |
Enhanced sensitivity of the MRL/MpJ mouse to the neuroplastic and behavioral effects of chronic antidepressant treatments.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Brain; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cell Proliferation; Desipramine; Eating; Exploratory Behavior; Flow Cytometry; Fluoxetine; Mice; Mice, Inbred Strains; Neurogenesis; Neuronal Plasticity; Neurons; Reaction Time | 2009 |
Co-treatment with diazepam prevents the effects of fluoxetine on the proliferation and survival of hippocampal dentate granule cells.
Topics: Animals; Bromodeoxyuridine; Cell Proliferation; Cell Survival; Diazepam; DNA; Drug Combinations; Fluoxetine; GABA Modulators; Hippocampus; Male; Mice; Mice, Inbred C57BL; Neurons; Selective Serotonin Reuptake Inhibitors; Time Factors | 2009 |
Notch1 signaling, hippocampal neurogenesis and behavioral responses to chronic unpredicted mild stress in adult ischemic rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Bromodeoxyuridine; Conditioning, Operant; Disease Models, Animal; Fluoxetine; Glial Fibrillary Acidic Protein; Hippocampus; Infarction, Middle Cerebral Artery; Male; Neurogenesis; Phosphopyruvate Hydratase; Rats; Rats, Sprague-Dawley; Receptor, Notch1; Selective Serotonin Reuptake Inhibitors; Signal Transduction; Stress, Psychological; Swimming; Time Factors | 2009 |
Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Anxiety; Arrestins; beta-Arrestin 2; beta-Arrestins; Bromodeoxyuridine; Cell Proliferation; Cell Survival; Corticosterone; Depression; Disease Models, Animal; Doublecortin Domain Proteins; Drug Administration Schedule; Exploratory Behavior; Feeding Behavior; Fluoxetine; Gene Expression Regulation; GTP-Binding Protein alpha Subunit, Gi2; Hippocampus; Hypothalamus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microtubule-Associated Proteins; Neurogenesis; Neuropeptides; Radiation; Reaction Time; RNA, Messenger | 2009 |
Induction of neuronal vascular endothelial growth factor expression by cAMP in the dentate gyrus of the hippocampus is required for antidepressant-like behaviors.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cell Line, Transformed; Chromatin Immunoprecipitation; CREB-Binding Protein; Cyclic AMP; Dentate Gyrus; Depression; Disease Models, Animal; Electrophoretic Mobility Shift Assay; Exploratory Behavior; Feeding Behavior; Fluoxetine; Food Preferences; Gene Expression Regulation; Humans; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurogenesis; Neurons; Octopamine; Receptors, Biogenic Amine; RNA, Small Interfering; Transfection; Vascular Endothelial Growth Factor A; Vasoconstrictor Agents | 2009 |
Prozac during puberty: distinctive effects on neurogenesis as a function of age and sex.
Topics: Aging; Animals; Antidepressive Agents, Second-Generation; Bromodeoxyuridine; Cell Proliferation; Cell Survival; Corticosterone; Female; Fluoxetine; Male; Neurogenesis; Random Allocation; Rats; Rats, Sprague-Dawley; Sex Characteristics; Sexual Maturation; Time Factors | 2009 |
Increased cellular turnover in response to fluoxetine in neuronal precursors derived from human embryonic stem cells.
Topics: Antidepressive Agents, Second-Generation; Apoptosis; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cell Differentiation; Cell Line; Cell Proliferation; Cyclic AMP Response Element-Binding Protein; Depressive Disorder; Embryo, Mammalian; Embryonic Stem Cells; Fluoxetine; Humans; Nerve Growth Factors; Neuronal Plasticity; Neurons; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
p75 neurotrophin receptor regulates basal and fluoxetine-stimulated hippocampal neurogenesis.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Bromodeoxyuridine; Cell Count; Dentate Gyrus; Flow Cytometry; Fluoxetine; Hippocampus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurogenesis; Neurons; Receptors, Nerve Growth Factor | 2010 |
Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice.
Topics: Acetamides; Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cell Death; Cell Proliferation; Doublecortin Domain Proteins; Drug Administration Schedule; Fluoxetine; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hindlimb Suspension; Hippocampus; In Situ Nick-End Labeling; Male; Mice; Mice, Transgenic; Microtubule-Associated Proteins; Neuronal Plasticity; Neuropeptides; Rats; Receptors, Glucocorticoid; RNA, Messenger | 2010 |
Macrophage migration inhibitory factor is critically involved in basal and fluoxetine-stimulated adult hippocampal cell proliferation and in anxiety, depression, and memory-related behaviors.
Topics: Acoustic Stimulation; Animals; Antidepressive Agents, Second-Generation; Anxiety; Bromodeoxyuridine; C-Reactive Protein; Cell Proliferation; Conditioning, Psychological; Corticosterone; Depression; Disease Models, Animal; Fear; Fluoxetine; Hippocampus; Macrophage Migration-Inhibitory Factors; Maze Learning; Memory Disorders; Mice; Mice, Knockout; Microscopy, Confocal; Nerve Tissue Proteins; Neurogenesis; Rats; Rats, Wistar; Receptors, Steroid; Spatial Behavior | 2011 |
Fluoxetine attenuates the inhibitory effect of glucocorticoid hormones on neurogenesis in vitro via a two-pore domain potassium channel, TREK-1.
Topics: Analysis of Variance; Animals; Bromodeoxyuridine; Cell Death; Cell Differentiation; Cell Proliferation; Drug Interactions; Embryo, Mammalian; Fluoxetine; Gene Expression Regulation; Glucocorticoids; Hippocampus; Humans; In Situ Nick-End Labeling; Intermediate Filament Proteins; Nerve Tissue Proteins; Nestin; Neural Inhibition; Neural Stem Cells; Neurogenesis; Potassium Channels, Tandem Pore Domain; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Transfection | 2011 |
Chronic treatment with fluoxetine for more than 6 weeks decreases neurogenesis in the subventricular zone of adult mice.
Topics: Aging; Animals; Bromodeoxyuridine; Calbindins; Cell Count; Cell Proliferation; Cerebral Ventricles; Dentate Gyrus; DNA-Binding Proteins; Fluoxetine; Ki-67 Antigen; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neurogenesis; Nuclear Proteins; Olfactory Bulb; S100 Calcium Binding Protein G; Time Factors | 2011 |
Novel control by the CA3 region of the hippocampus on neurogenesis in the dentate gyrus of the adult rat.
Topics: Aging; Animals; Bromodeoxyuridine; CA3 Region, Hippocampal; Calbindins; Cell Count; Cell Proliferation; Cell Survival; Dentate Gyrus; Fluoxetine; Ibotenic Acid; Male; Mitosis; Neural Stem Cells; Neurogenesis; Neurons; Rats; Rats, Sprague-Dawley; S100 Calcium Binding Protein G; Staining and Labeling; Time Factors | 2011 |
A novel flow cytometry-based technique to measure adult neurogenesis in the brain.
Topics: Animals; Antimetabolites; Brain; Bromodeoxyuridine; Cell Count; Cell Nucleus; Centrifugation, Density Gradient; DNA-Binding Proteins; Flow Cytometry; Fluoxetine; Hippocampus; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nerve Tissue Proteins; Neurogenesis; Nuclear Proteins; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors | 2011 |
5-HT(2B) receptors are required for serotonin-selective antidepressant actions.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Bromodeoxyuridine; Cell Differentiation; Chromatography, High Pressure Liquid; Exploratory Behavior; Fluoxetine; Gene Expression Regulation; Hippocampus; Hypothermia; Ki-67 Antigen; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Neurogenesis; Reaction Time; Receptor, Serotonin, 5-HT2B; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Time Factors; Transcription Factors | 2012 |
BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity.
Topics: Analysis of Variance; Animals; Biophysics; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Dentate Gyrus; Electric Stimulation; Enzyme-Linked Immunosorbent Assay; Fluoxetine; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Humans; In Vitro Techniques; Long-Term Potentiation; Male; Methionine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Patch-Clamp Techniques; Polymorphism, Single Nucleotide; Receptor, trkB; Selective Serotonin Reuptake Inhibitors; Valine | 2012 |
Fluoxetine counteracts the cognitive and cellular effects of 5-fluorouracil in the rat hippocampus by a mechanism of prevention rather than recovery.
Topics: Animals; Antidepressive Agents, Second-Generation; Antimetabolites, Antineoplastic; Body Weight; Bromodeoxyuridine; Cell Proliferation; Cognition Disorders; Dentate Gyrus; Drinking; Fluorouracil; Fluoxetine; Hippocampus; Ki-67 Antigen; Male; Memory; Rats; Space Perception; Time Factors; Weight Gain | 2012 |
Antidepressant effects of fibroblast growth factor-2 in behavioral and cellular models of depression.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Bromodeoxyuridine; Depressive Disorder; Disease Models, Animal; Fibroblast Growth Factor 2; Fluoxetine; Imipramine; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Neuroglia; Prefrontal Cortex; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Fibroblast Growth Factor; Stress, Psychological | 2012 |
MPTP-induced hippocampal effects on serotonin, dopamine, neurotrophins, adult neurogenesis and depression-like behavior are partially influenced by fluoxetine in adult mice.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Bromodeoxyuridine; Cell Count; Conditioning, Operant; Dark Adaptation; Depression; Disease Models, Animal; Dopamine; Enzyme-Linked Immunosorbent Assay; Female; Fluoxetine; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Green Fluorescent Proteins; Hippocampus; Intermediate Filament Proteins; Mice; Mice, Transgenic; MPTP Poisoning; Nerve Growth Factors; Nerve Tissue Proteins; Nestin; Random Allocation; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT1; Reflex, Startle; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin | 2012 |
Differential environmental regulation of neurogenesis along the septo-temporal axis of the hippocampus.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Antimetabolites; Anxiety; Bromodeoxyuridine; Cell Proliferation; Depression; Dose-Response Relationship, Drug; Eating; Environment; Fluoxetine; Grooming; Hair; Hippocampus; Male; Memory; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Motor Activity; Neurogenesis; Recognition, Psychology; Stress, Psychological | 2012 |
Neurogenesis-independent antidepressant-like effects on behavior and stress axis response of a dual orexin receptor antagonist in a rodent model of depression.
Topics: Acetamides; Animals; Antidepressive Agents; Behavior, Animal; Biomarkers; Bromodeoxyuridine; Cell Proliferation; Depression; Disease Models, Animal; Doublecortin Domain Proteins; Fluoxetine; Hypothalamo-Hypophyseal System; Intracellular Signaling Peptides and Proteins; Isoquinolines; Ki-67 Antigen; Mice; Mice, Inbred BALB C; Microtubule-Associated Proteins; Neurogenesis; Neuropeptides; Orexin Receptors; Orexins; Pituitary-Adrenal System; Receptors, G-Protein-Coupled; Receptors, Neuropeptide | 2012 |
Region-dependent and stage-specific effects of stress, environmental enrichment, and antidepressant treatment on hippocampal neurogenesis.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Bromodeoxyuridine; Calbindin 2; Cell Count; Disease Models, Animal; Doublecortin Domain Proteins; Environment; Fluoxetine; Hippocampus; Homeodomain Proteins; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Microtubule-Associated Proteins; Neurogenesis; Neuropeptides; Stress, Psychological; Tumor Suppressor Proteins | 2013 |
Quetiapine add-on therapy improves the depressive behaviors and hippocampal neurogenesis in fluoxetine treatment resistant depressive rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Antimetabolites; Antipsychotic Agents; Bromodeoxyuridine; Cell Count; Cell Proliferation; Depressive Disorder; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Eating; Environment; Fluoxetine; Hippocampus; Immunohistochemistry; Male; Neurogenesis; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Stress, Psychological; Sucrose; Swimming; Tissue Fixation | 2013 |
Fluoxetine pretreatment promotes neuronal survival and maturation after auditory fear conditioning in the rat amygdala.
Topics: Acoustic Stimulation; Amygdala; Animals; Antidepressive Agents, Second-Generation; Astrocytes; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Cell Survival; Conditioning, Classical; Fear; Fluoxetine; Hippocampus; Male; Neurogenesis; Neurons; Rats; Rats, Sprague-Dawley | 2014 |
Mice with ablated adult brain neurogenesis are not impaired in antidepressant response to chronic fluoxetine.
Topics: Animals; Antidepressive Agents; Bromodeoxyuridine; Chronic Disease; Cyclin D2; Depression; Exploratory Behavior; Fluoxetine; Hippocampus; Immunohistochemistry; Male; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Neurogenesis; Neuropsychological Tests; Swimming; Uncertainty | 2014 |
Chronic fluoxetine increases extra-hippocampal neurogenesis in adult mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cell Proliferation; Cyclic AMP Response Element-Binding Protein; Doublecortin Domain Proteins; Fluoxetine; Habenula; Hippocampus; Hypothalamus; Immunohistochemistry; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Transgenic; Microtubule-Associated Proteins; Nestin; Neural Stem Cells; Neurogenesis; Neuroglia; Neuropeptides; RNA, Messenger | 2014 |
A simple assessment model to quantifying the dynamic hippocampal neurogenic process in the adult mammalian brain.
Topics: Animals; Area Under Curve; Bromodeoxyuridine; Cell Count; Cell Death; Cell Proliferation; Cell Survival; Central Nervous System Agents; Doublecortin Domain Proteins; Fluoxetine; Hippocampus; Image Processing, Computer-Assisted; Ki-67 Antigen; Male; Mice, Inbred C57BL; Microtubule-Associated Proteins; Models, Neurological; Neurogenesis; Neurons; Neuropeptides; Time Factors | 2016 |